Answers are grounded in this paper and cite their sources.
AIM: To characterize systemic transcriptomic signatures and identify candidate hub genes associated with lung squamous cell carcinoma (LSCC) in peripheral blood using an integrative systems-biology approach. MATERIALS AND METHODS: Peripheral blood transcriptomic data from GSE252168 (32 LSCC and 32 controls) were analyzed using GEO2R/limma. Differentially expressed genes (DEGs) were subjected to protein-protein interaction, functional enrichment, network-hub, transcription-factor motif, and exploratory DrugBank analyses. Fifteen prespecified hub genes were evaluated in an independent whole-blood cohort (GSE198048) and compared with primary tumor tissue from TCGA-LUSC (511 tumors, 51 normal samples). KLF12, KLF16, and KLF9 were identified as putative upstream regulators. Five hub genes (RPL10A, RPL22, RPS4X, RPS27A, and RPS14) showed targeted external replication within the prespecified 15-gene panel, all being downregulated. In TCGA-LUSC, 10/15 hub genes were differentially expressed, while only 5/15 showed directional concordance with blood. CONCLUSION: Peripheral blood transcriptomics reveals systemic molecular alterations in LSCC, with candidate hub genes and pathways requiring independent and experimental validation.
No takes yet. Share an insight, caveat, or question.
Farzadifar et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: